Annabell Wolff
Rostock, MV, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Th17-mediated antitumor immunity in patient-derived organoid and autologous immune cell cocultures predicts response to immunotherapy in head and neck cancer.
Journal: Immuno-oncology technology
Published: June 15, 2026
Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation.
Journal: Cellular and molecular neurobiology
Published: March 09, 2026
Machine learning-guided multimodal profiling defines perturbed immune states at the time of cancer diagnosis.
Journal: Briefings in bioinformatics
Published: February 06, 2026
The coagulation-inflammation axis in advanced cancer: associations with cardiovascular-thrombotic complications.
Journal: Journal of thrombosis and thrombolysis
Published: November 09, 2025
Exploring the dual role of extracellular vesicles in coagulation and immune modulation in glioblastoma.
Journal: Scientific reports
Published: October 22, 2025
Tumor treating fields alter local coagulation dynamics in glioblastoma patients.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 13, 2025
Immune-checkpoint inhibition for tumor prevention in a preclinical Lynch syndrome model.
Journal: Translational oncology
Published: February 28, 2025
Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma.
Journal: NPJ precision oncology
Published: January 10, 2024
Prophylaxis with abemaciclib delays tumorigenesis in dMMR mice by altering immune responses and reducing immunosuppressive extracellular vesicle secretion.
Journal: Translational oncology
Published: November 15, 2023
Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer.
Journal: Scientific reports
Published: September 04, 2023
Short-term immune-checkpoint inhibition partially rescues perturbed bone marrow hematopoiesis in mismatch-repair deficient tumors.
Journal: Oncoimmunology
Published: July 03, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026